All In Biotech

Free tool

FAERS Monitor: Crinone

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020701 or its brand name (Crinone, Progesterone). Reports on generic versions are filed under their own applications.

Reports

20,427

Serious

11,188

55% of reports

Hospitalization

3,238

Death reported

490

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • headache1,893
  • off label use1,733
  • drug ineffective1,678
  • fatigue1,598
  • pain1,348
  • nausea1,325
  • exposure during pregnancy945
  • rash932
  • foetal exposure during pregnancy915
  • hypersensitivity823
  • dizziness818
  • maternal exposure during pregnancy807
  • hyperhidrosis793
  • product use issue789
  • diarrhoea728

Reports by year received

View as table
YearReports
2004138
2005157
2006146
2007118
2008174
2009241
2010278
2011246
2012393
2013365
2014471
2015836
20161,229
2017993
20181,093
20191,241
20201,288
20211,252
20221,426
20231,606
20241,998
20252,234
20262,504

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,033,732 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
exposure during pregnancySignal94515.914.913,001
foetal exposure during pregnancySignal91511.711.08,887
maternal exposure during pregnancySignal8079.48.86,019
hyperhidrosisSignal7936.46.03,586
hypersensitivitySignal8234.64.32,310
product use issueSignal7894.34.02,032
headacheSignal1,8933.13.02,792
painSignal1,3482.32.1975
rashSignal9322.22.1623
fatigueSignal1,5982.12.0973
off label useSignal1,7332.01.9956
nausea1,3251.71.6418
dizziness8181.71.6235
drug ineffective1,6781.31.3132
diarrhoea7281.21.117

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.